Detalles de la búsqueda
1.
Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata.
Br J Cancer
; 129(9): 1490-1499, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37684354
2.
The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma.
Br J Cancer
; 118(5): 698-704, 2018 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29235571
3.
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.
Lancet Rheumatol
; 6(6): e339-e351, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38734019
4.
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease.
Nat Med
; 29(7): 1760-1774, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37414897
5.
Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study.
Eur Urol
; 80(1): 12-15, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33653635
6.
Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial.
Lancet
; 373(9663): 567-74, 2009 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-19217991
7.
Development and validation of a follow-up methodology for a randomised controlled trial, utilising routine clinical data as an alternative to traditional designs: a pilot study to assess the feasibility of use for the BladderPath trial.
Pilot Feasibility Stud
; 6(1): 165, 2020 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33292682
Resultados
1 -
7
de 7
1
Próxima >
>>